These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8506004)

  • 1. [Endometrial carcinoma during estrogen replacement therapy in spite of addition of progestagens].
    Ubachs JM; Heineman MJ
    Ned Tijdschr Geneeskd; 1993 May; 137(21):1062-3. PubMed ID: 8506004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endometrial carcinoma during estrogen replacement therapy in spite of addition of progestagens].
    Meuwissen JH; Klinkhamer PJ; Brölmann HA; Wiegerinck MA
    Ned Tijdschr Geneeskd; 1993 Jul; 137(29):1473. PubMed ID: 8361563
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estrogen plus gestagen especially risky. Breast cancer risk doubled].
    MMW Fortschr Med; 2003 Nov; 145(46):8. PubMed ID: 14699823
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone replacement therapy in menopause].
    Breckwoldt M
    Dtsch Med Wochenschr; 2003 Feb; 128(8):400. PubMed ID: 12594630
    [No Abstract]   [Full Text] [Related]  

  • 6. An atypical recurrence of endometrial carcinoma following estrogen replacement therapy.
    Carr JA; Schoon PA; Look KY
    Gynecol Oncol; 1996 Mar; 60(3):498-9. PubMed ID: 8774666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estrogen therapy after uterine cancer?].
    Bock JE
    Ugeskr Laeger; 1996 Mar; 158(12):1691. PubMed ID: 8644419
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD
    Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer.
    Comerci JT; Fields AL; Runowicz CD; Goldberg GL
    Gynecol Oncol; 1997 Mar; 64(3):425-30. PubMed ID: 9062144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer.
    Reed SD; Voigt LF; Beresford SA; Hill DA; Doherty JA; Weiss NS
    Am J Obstet Gynecol; 2004 Oct; 191(4):1146-51. PubMed ID: 15507934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protecting the endometrium. Opposing the hyperplasia/malignancy potential of ERT.
    Gibbons WE; Thorneycroft IH
    J Reprod Med; 1999 Feb; 44(2 Suppl):203-8. PubMed ID: 11392033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement: HERS study was no revolution.
    Ylikorkala O
    Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1029-36. PubMed ID: 11130082
    [No Abstract]   [Full Text] [Related]  

  • 13. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
    Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
    Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Requiem for hormone replacement therapy? This does not apply to modern preparations!].
    Lippert TH; Mueck AO
    MMW Fortschr Med; 2003 Sep; 145(37):13; author reply 13-4. PubMed ID: 14584434
    [No Abstract]   [Full Text] [Related]  

  • 15. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
    Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.
    Barakat RR; Bundy BN; Spirtos NM; Bell J; Mannel RS;
    J Clin Oncol; 2006 Feb; 24(4):587-92. PubMed ID: 16446331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Heart and Estrogen/Progestin Replacement Study (HERS) in perspective--results not very surprising.
    Naessen T
    Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1037-41. PubMed ID: 11130083
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of estrogen-progestins in secondary prevention].
    Modena MG; Origliani G; Rossi R
    Ital Heart J Suppl; 2000 Mar; 1(3):435-6. PubMed ID: 10815281
    [No Abstract]   [Full Text] [Related]  

  • 19. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
    Twombly R
    J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone therapy's unanswered questions.
    Harv Womens Health Watch; 2004 Jul; 11(11):1. PubMed ID: 15273055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.